Nutrition, Metabolism & Cardiovascular Diseases
Volume 20, Issue 2 , Pages 101-109 , February 2010

Acute effects of casein on postprandial lipemia and incretin responses in type 2 diabetic subjects

  • L. Brader

      Affiliations

    • Department of Endocrinology and Metabolism, Aarhus University Hospital, Aarhus Sygehus THG, Denmark
    • ,
  • L. Holm

      Affiliations

    • Department of Endocrinology and Metabolism, Aarhus University Hospital, Aarhus Sygehus THG, Denmark
    • ,
  • L. Mortensen

      Affiliations

    • Department of Endocrinology and Metabolism, Aarhus University Hospital, Aarhus Sygehus THG, Denmark
    • ,
  • C. Thomsen

      Affiliations

    • Department of Endocrinology and Metabolism, Aarhus University Hospital, Aarhus Sygehus THG, Denmark
    • ,
  • A. Astrup

      Affiliations

    • Research Department of Human Nutrition, University of Copenhagen, Denmark
    • ,
  • J.J. Holst

      Affiliations

    • Department of Biomedical Sciences, The Panum Institute, University of Copenhagen, Denmark
    • ,
  • M. de Vrese

      Affiliations

    • Institute of Physiology and Biochemistry of Nutrition, Federal Research Centre of Nutrition and Food, Kiel, Germany
    • ,
  • J. Schrezenmeir

      Affiliations

    • Institute of Physiology and Biochemistry of Nutrition, Federal Research Centre of Nutrition and Food, Kiel, Germany
    • ,
  • K. Hermansen

      Affiliations

    • Department of Endocrinology and Metabolism, Aarhus University Hospital, Aarhus Sygehus THG, Denmark
    • Research Department of Human Nutrition, University of Copenhagen, Denmark
    • Corresponding Author InformationCorrespondence to: Kjeld Hermansen, Department of Endocrinology and Metabolism, Aarhus University Hospital, Aarhus Sygehus THG, 8000 Aarhus C, Denmark. Tel.: +45 89497650; fax: +45 86193807.

Received 22 October 2008 ,Revised 22 December 2008 ,Accepted 10 March 2009.

References 

  1. Rivellese AA, De NC, Di ML, Patti L, Iovine C, Coppola S, et al. Exogenous and endogenous postprandial lipid abnormalities in type 2 diabetic patients with optimal blood glucose control and optimal fasting triglyceride levels. J Clin Endocrinol Metab. 2004 May;89(5):2153–2159
  2. Zilversmit DB. Atherogenesis: a postprandial phenomenon. Circulation. 1979 Sep;60(3):473–485
  3. Proctor SD, Mamo JC. Retention of fluorescent-labelled chylomicron remnants within the intima of the arterial wall–evidence that plaque cholesterol may be derived from post-prandial lipoproteins. Eur J Clin Invest. 1998 Jun;28(6):497–503
  4. Karpe F, Steiner G, Uffelman K, Olivecrona T, Hamsten A. Postprandial lipoproteins and progression of coronary atherosclerosis. Atherosclerosis. 1994 Mar;106(1):83–97
  5. Bansal S, Buring JE, Rifai N, Mora S, Sacks FM, Ridker PM. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA. 2007 Jul 18;298(3):309–316
  6. Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA. 2007 Jul 18;298(3):299–308
  7. Thomsen C, Rasmussen O, Lousen T, Holst JJ, Fenselau S, Schrezenmeir J, et al. Differential effects of saturated and monounsaturated fatty acids on postprandial lipemia and incretin responses in healthy subjects. Am J Clin Nutr. 1999 Jun;69(6):1135–1143
  8. Thomsen C, Storm H, Holst JJ, Hermansen K. Differential effects of saturated and monounsaturated fats on postprandial lipemia and glucagon-like peptide 1 responses in patients with type 2 diabetes. Am J Clin Nutr. 2003 Mar;77(3):605–611
  9. Jeppesen J, Chen YD, Zhou MY, Wang T, Reaven GM. Effect of variations in oral fat and carbohydrate load on postprandial lipemia. Am J Clin Nutr. 1995 Dec;62(6):1201–1205
  10. Sullivan JF. The effect of protein ingestion on alimentary lipemia. Am J Med Sci. 1962 Jun;243:770–774
  11. Gannon MC, Nuttall FQ, Saeed A, Jordan K, Hoover H. An increase in dietary protein improves the blood glucose response in persons with type 2 diabetes. Am J Clin Nutr. 2003 Oct;78(4):734–741
  12. Holst JJ, Orskov C. Incretin hormones – an update. Scand J Clin Lab Invest Suppl. 2001;234:75–85
  13. Meier JJ, Gethmann A, Gotze O, Gallwitz B, Holst JJ, Schmidt WE, et al. Glucagon-like peptide 1 abolishes the postprandial rise in triglyceride concentrations and lowers levels of non-esterified fatty acids in humans. Diabetologia. 2006 Mar;49(3):452–458
  14. Blomhoff R, Green MH, Green JB, Berg T, Norum KR. Vitamin A metabolism: new perspectives on absorption, transport, and storage. Physiol Rev. 1991 Oct;71(4):951–990
  15. Krarup T, Madsbad S, Moody AJ, Regeur L, Faber OK, Holst JJ, et al. Diminished immunoreactive gastric inhibitory polypeptide response to a meal in newly diagnosed type I (insulin-dependent) diabetics. J Clin Endocrinol Metab. 1983 Jun;56(6):1306–1312
  16. Hvidberg A, Nielsen MT, Hilsted J, Orskov C, Holst JJ. Effect of glucagon-like peptide-1 (proglucagon 78-107amide) on hepatic glucose production in healthy man. Metabolism. 1994 Jan;43(1):104–108
  17. Holst JJ. Evidence that enteroglucagon (II) is identical with the C-terminal sequence (residues 33-69) of glicentin. Biochem J. 1982 Dec 1;207(3):381–388
  18. Schrezenmeir J, Weber P, Probst R, Biesalski HK, Luley C, Prellwitz W, et al. Postprandial pattern of triglyceride-rich lipoprotein in normal-weight humans after an oral lipid load: exaggerated triglycerides and altered insulin response in some subjects. Ann Nutr Metab. 1992;36(4):186–196
  19. Carstensen M, Thomsen C, Hermansen K. Incremental area under response curve more accurately describes the triglyceride response to an oral fat load in both healthy and type 2 diabetic subjects. Metabolism. 2003 Aug;52(8):1034–1037
  20. Cohen JC. Protein ingestion does not affect postprandial lipaemia or chylomicron-triglyceride clearance. Eur J Clin Nutr. 1989 Jul;43(7):497–499
  21. Westphal S, Kastner S, Taneva E, Leodolter A, Dierkes J, Luley C. Postprandial lipid and carbohydrate responses after the ingestion of a casein-enriched mixed meal. Am J Clin Nutr. 2004 Aug;80(2):284–290
  22. Westphal S, Taneva E, Kastner S, Martens-Lobenhoffer J, Bode-Boger S, Kropf S, et al. Endothelial dysfunction induced by postprandial lipemia is neutralized by addition of proteins to the fatty meal. Atherosclerosis. 2006 Apr;185(2):313–319
  23. Gannon MC, Nuttall FQ, Lane JT, Burmeister LA. Metabolic response to cottage cheese or egg white protein, with or without glucose, in type II diabetic subjects. Metabolism. 1992 Oct;41(10):1137–1145
  24. Dalgaard M, Thomsen C, Rasmussen BM, Holst JJ, Hermansen K. Ethanol with a mixed meal decreases the incretin levels early postprandially and increases postprandial lipemia in type 2 diabetic patients. Metabolism. 2004 Jan;53(1):77–83
  25. Kolovou GD, Anagnostopoulou KK, Salpea KD, Daskalopoulou SS, Mikhailidis DP. The effect of statins on postprandial lipemia. Curr Drug Targets. 2007 Apr;8(4):551–560
  26. Nilsson M, Stenberg M, Frid AH, Holst JJ, Bjorck IM. Glycemia and insulinemia in healthy subjects after lactose-equivalent meals of milk and other food proteins: the role of plasma amino acids and incretins. Am J Clin Nutr. 2004 Nov;80(5):1246–1253
  27. Nordt TK, Besenthal I, Eggstein M, Jakober B. Influence of breakfasts with different nutrient contents on glucose, C peptide, insulin, glucagon, triglycerides, and GIP in non-insulin-dependent diabetics. Am J Clin Nutr. 1991 Jan;53(1):155–160
  28. Holst JJ, Gromada J. Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans. Am J Physiol Endocrinol Metab. 2004 Aug;287(2):E199–E206
  29. Vilsboll T, Krarup T, Sonne J, Madsbad S, Volund A, Juul AG, et al. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus. J Clin Endocrinol Metab. 2003 Jun;88(6):2706–2713
  30. Linn T, Santosa B, Gronemeyer D, Aygen S, Scholz N, Busch M, et al. Effect of long-term dietary protein intake on glucose metabolism in humans. Diabetologia. 2000 Oct;43(10):1257–1265
  31. Dolais-Kitabgi J, Freychet P. Neurotensin inhibits glucose but not glucagon-induced insulin and somatostatin release in isolated islets. Diabete Metab. 1979 Dec;5(4):275–277

☆ Sponsorship: this work is carried out as part of the research program of the Danish Obesity Research Centre (DanORC, see www.danorc.dk). It is furthermore supported by the Nordic Centre of Excellence (NCoE) programme (Systems biology in controlled dietary interventions and cohort studies – SYSDIET, P No., 070014) and the Danish Diabetes Association.

PII: S0939-4753(09)00062-3

doi: 10.1016/j.numecd.2009.03.019

Nutrition, Metabolism & Cardiovascular Diseases
Volume 20, Issue 2 , Pages 101-109 , February 2010

Article Tools

* Image Usage & Resolution